Differences between revisions 1 and 4 (spanning 3 versions)
Revision 1 as of 2008-07-10 17:13:31
Size: 537
Editor: GaryBader
Comment:
Revision 4 as of 2008-07-17 13:26:32
Size: 1043
Editor: GaryBader
Comment:
Deletions are marked like this. Additions are marked like this.
Line 8: Line 8:
This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions.

= Attendees =
 * Trey Ideker
 * Gary Bader
 * Annette Adler
 * Alex Pico (in lieu of Bruce)
 * Benno Schwikowski
 * Chris Sander
 * Charlie Boone
 * Mark Gerstein
 * Shoshana Wodak
Line 11: Line 23:
 * Item 1
 * Item 2
 * Update on Cytoscape (Mike Smoot)
 * New secretary/treasurer (Annette)
 * Cytoscape book - what's the goal? (Annette)
 * Funding (Trey)
 * Scientific directions

Cytoscape Board Meeting

Date: Saturday, July 19, 2008

Description

This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions.

Attendees

  • Trey Ideker
  • Gary Bader
  • Annette Adler
  • Alex Pico (in lieu of Bruce)
  • Benno Schwikowski
  • Chris Sander
  • Charlie Boone
  • Mark Gerstein
  • Shoshana Wodak

Agenda

  • Update on Cytoscape (Mike Smoot)
  • New secretary/treasurer (Annette)
  • Cytoscape book - what's the goal? (Annette)
  • Funding (Trey)
  • Scientific directions

Notes

CytoscapeRetreat2008/BoardMeeting (last edited 2009-02-12 01:03:27 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux